Fibronectin extra domain A as a drug delivery targeting epitope for rheumatoid arthritis

被引：0
|
作者：
Victor Z. Sun
Terry L. Melim
Soumya Mitra
Jamie E. Erickson
Shaughn H. Bryant
Avery Farnham
Susan Westmoreland
Heather Knight
Liang Zhang
Wendy Ritacco
Kristoff Homan
Lorenzo Benatuil
Annette J. Schwartz Sterman
Andrew D. Goodearl
机构：
[1] Drug Discovery Science and Technology,
[2] Abbvie Bioresearch Center,undefined
[3] Generate Biomedicines,undefined
[4] Bristol Myers Squibb,undefined
[5] Dragonfly Therapeutics Inc,undefined
来源：
Advances in Rheumatology | / 62卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Fibronectin extra domain A as a drug delivery targeting epitope for rheumatoid arthritis
    Sun, Victor Z.
    Melim, Terry L.
    Mitra, Soumya
    Erickson, Jamie E.
    Bryant, Shaughn H.
    Farnham, Avery
    Westmoreland, Susan
    Knight, Heather
    Zhang, Liang
    Ritacco, Wendy
    Homan, Kristoff
    Benatuil, Lorenzo
    Sterman, Annette J. Schwartz
    Goodearl, Andrew D.
    [J]. ADVANCES IN RHEUMATOLOGY, 2022, 62 (01)
  • [2] Receptor targeting drug delivery strategies and prospects in the treatment of rheumatoid arthritis
    Emami, Jaber
    Ansarypour, Zahra
    [J]. RESEARCH IN PHARMACEUTICAL SCIENCES, 2019, 14 (06) : 471 - 487
  • [3] Drug Targeting and Nanotherapeutic Advancement in the Treatment of Rheumatoid Arthritis: Recent Progress in Drug Delivery Systems
    Deshmukh, Rohitas
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024,
  • [4] Extra Domain B Fibronectin as a Target for Near-Infrared Fluorescence Imaging of Rheumatoid Arthritis Affected Joints In Vivo
    Vollmer, Sonja
    Vater, Axel
    Licha, Kai
    Gemeinhardt, Ines
    Gemeinhardt, Ole
    Voigt, Jan
    Ebert, Bernd
    Schnorr, Joerg
    Taupitz, Matthias
    Macdonald, Rainer
    Schirner, Michael
    [J]. MOLECULAR IMAGING, 2009, 8 (06): : 330 - 340
  • [5] Targeting a rheumatoid arthritis drug to inflamed joints
    Katsnelson, Alla
    [J]. CHEMICAL & ENGINEERING NEWS, 2019, 97 (19) : 10 - 10
  • [6] Fibronectin: extra domain brings extra risk?
    Wang, Yiming
    Ni, Heyu
    [J]. BLOOD, 2015, 125 (20) : 3043 - +
  • [7] Drug delivery systems for the treatment of rheumatoid arthritis
    Tarner, Ingo H.
    Mueller-Ladner, Ulf
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2008, 5 (09) : 1027 - 1037
  • [8] Rheumatoid Arthritis: Conjugating Basics with Drug Delivery
    Balar, Hemen
    Shah, Tejas
    Agrawal, Y. K.
    [J]. CURRENT RHEUMATOLOGY REVIEWS, 2011, 7 (03) : 253 - 262
  • [9] Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
    Martin-Otal, Celia
    Lasarte-Cia, Aritz
    Serrano, Diego
    Casares, Noelia
    Conde, Enrique
    Navarro, Flor
    Sanchez-Moreno, Ines
    Gorraiz, Marta
    Sarrion, Patricia
    Calvo, Alfonso
    De Andrea, Carlos E.
    Echeveste, Jose
    Vilas, Amaia
    Rodriguez-Madoz, Juan Roberto
    San Miguel, Jesus
    Prosper, Felipe
    Hervas-Stubbs, Sandra
    Lasarte, Juan Jose
    Lozano, Teresa
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (08)
  • [10] Synovial fibronectin fragmentation and domain expressions in relation to rheumatoid arthritis progression
    Przybysz, M.
    Borysewicz, K.
    Szechifiski, J.
    Katnik-Prastowska, I.
    [J]. RHEUMATOLOGY, 2007, 46 (07) : 1071 - 1075
12345